RecruitingPhase 3NCT05615844

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

A Randomized Controlled Trial Comparing Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy for the Management of Severe Open Tibia Fracture Wounds


Sponsor

University of Maryland, Baltimore

Enrollment

312 participants

Start Date

Nov 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participants will be randomized to receive either an antibiotic bead pouch or negative pressure wound therapy (NPWT) for their temporary open fracture wound management. Outcomes will be assessed at 6 weeks, 3 months, and 6 months post-surgery. The primary outcome will be a composite outcome to evaluate clinical status six months after randomization. Components of the composite outcome will be hierarchically assessed in the following order: 1) all-cause mortality, 2) injury-related amputation of the lower extremity, 3) unplanned reoperation to manage wound complications, infection, or delayed fracture healing, and 4) clinical fracture healing as assessed using the Functional IndeX for Trauma (FIX-IT) instrument. The secondary outcomes will independently assess the four components of the primary outcome. This is a Phase III trial.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Patients 18 years of age or older.
  • Severe open tibia fracture requiring more than one irrigation and debridement procedure to treat the open fracture.
  • Planned internal or external fixation for definitive fracture management.
  • Formal surgical debridement within 72 hours of their injury.
  • Will have all planned fracture care surgeries performed by a participating surgeon or delegate.
  • Informed consent obtained.

Exclusion Criteria12

  • Due to the severity of injury, the treating surgeon does not believe limb salvage \>6 months is likely to be successful based on the emergency department or initial intraoperative assessment (prior to enrolment and randomization).
  • Medical contraindication to antibiotic beads, including previously known allergies or sensitivities to vancomycin and/or tobramycin.
  • Medical or injury contraindication to NPWT. Injury contraindications could include situations in which the NPWT could not be placed over a vascular graft or exposed neurovascular structure.
  • Received previous surgical debridement or management of their fracture at a non-participating hospital or clinic (as applicable).
  • Chronic or acute infection at or near the fracture site at the time of initial fracture surgery.
  • Incarceration.
  • Women of child-bearing potential who are pregnant or intending to become pregnant within the next 6 months.
  • Currently enrolled in a study that does not permit co-enrollment.
  • Unable to obtain informed consent due to language barriers.
  • Anticipated problems, in the judgment of research personnel, with maintaining follow-up with the patient.
  • Prior enrollment in the trial.
  • Other reason to exclude the patient, as approved by the Methods Center.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAntibiotic Cement Bead Pouch

The antibiotic bead pouch provides an antibiotic delivery mechanism. It is made by combining polymethyl methacrylate (PMMA) cement with generic forms of vancomycin and tobramycin powder.

DEVICENegative Pressure Wound Therapy

Standard application of negative pressure wound therapy


Locations(33)

Dignity Health Chandler Regional Medical Center

Chandler, Arizona, United States

University of California, Davis

Davis, California, United States

University of Southern California

Los Angeles, California, United States

Cedars-Sinai Medical Center

Los Angeles, California, United States

University of California, Irvine

Orange, California, United States

Yale University

New Haven, Connecticut, United States

University of Florida

Gainesville, Florida, United States

University of Miami

Miami, Florida, United States

Indiana University

Indianapolis, Indiana, United States

University of Maryland, R Adams Cowley Shock Trauma Center

Baltimore, Maryland, United States

University of Maryland Capital Region Health

Largo, Maryland, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

University of Mississippi

University, Mississippi, United States

Bryan Medical Center

Lincoln, Nebraska, United States

University Medical Center of Southern Nevada

Las Vegas, Nevada, United States

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States

Sanford Medical Center

Fargo, North Dakota, United States

University of Cincinnati

Cincinnati, Ohio, United States

Bon Secours Mercy Health

Cincinnati, Ohio, United States

Slocum Center

Eugene, Oregon, United States

Ortegon Health & Science University

Portland, Oregon, United States

St. Luke's University Health Network

Bethlehem, Pennsylvania, United States

Prisma Health - Midlands

Columbia, South Carolina, United States

Prisma Health

Greenville, South Carolina, United States

Sanford Health

Sioux Falls, South Dakota, United States

University of Utah

Salt Lake City, Utah, United States

Inova Fairfax

Falls Church, Virginia, United States

University of Wisconsin

Madison, Wisconsin, United States

Royal Columbian Hospital

New Westminster, British Columbia, Canada

University of British Columbia

Vancouver, British Columbia, Canada

Hamilton Health Sciences

Hamilton, Ontario, Canada

London Health Sciences Centre

London, Ontario, Canada

The Ottawa Hospital

Ottawa, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05615844


Related Trials